Psilocybin-assisted group therapy: A new hope for demoralization
EClinicalMedicine October 1, 2020 DOI: 10.1016/j.eclinm.2020.100557 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Citations | 5 |
| Key points | Argues that applying a group therapy paradigm to classic psychedelic treatment is innovative and important because individual psilocybin-assisted therapy is time-intensive and raises scalability concerns, and notes that group use of classic psychedelics, though uncommon in contemporary clinical studies, is consistent with the anthropology of these compounds. |
Abstract
It is innovative in applying a group therapy paradigm not previously used in contemporary clinical studies of classic psychedelics. This is important because psilocybin- and other classic psychedelic-assisted treatments are typically time-intensive, involving several lengthy individual pre-drug preparatory sessions and post-drug integration sessions, raising concerns about scalability in real-world settings. The use of group therapy with classic psychedelics, though uncommon, is consistent with the anthropology of these compounds [[2]Schultes R. E. Hallucinogens of plant origin. Science.
Citations in the library
Cited by 5
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors. Journal of Psychopharmacology February 28, 2023
- Break on Through: Betty Eisner's Problematic Use of Psychedelics, Groups, and Control for Integrative Experiences. Journal of the History of the Behavioral Sciences April 1, 2025
- Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey Journal of Psychedelic Studies April 22, 2025
- Psychedelics and neonihilism: connectedness in a meaningless world Frontiers in Psychology August 9, 2023
Cites 3
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics May 1, 2019
- Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study EClinicalMedicine September 24, 2020
- Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy International Review of Psychiatry July 4, 2018